Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Newly diagnosed myeloma patients (NDMM) are often on the lookout for the most effective myeloma diet. In the case of the studies linked below, the “most effective” is the myeloma diet that helps the NDMM patient build their health such that they are best prepared to manage their MM in the years to come.
In the interest of full transparency, I have to go on record as saying that several posts on PeopleBeatingCancer.org promote the Meditteranean Diet as the best myeloma diet. And I continue to believe that a diet rich in fruits and veggies and low on animal fat is important for NDMM patients.
But a growing number of studies cite the importance of a healthy gut for the ideal myeloma diet.
The gut microbiome is crucial for the development and functioning of the immune system. A healthy gut microbiome helps regulate immune responses and can influence the body’s ability to fight cancer cells. Disruptions in the gut microbiota can lead to immune system dysregulation, potentially affecting cancer progression and response to treatment.
An imbalance in the gut microbiota (dysbiosis) can lead to chronic inflammation, which is a known risk factor for various types of cancer. Chronic inflammation can promote cancer development and progression by creating an environment that supports tumor growth and survival.
Cancer treatments, such as chemotherapy and radiation therapy, often disrupt the gut microbiome, leading to gastrointestinal issues like diarrhea, constipation, and nausea. Maintaining a healthy gut can help mitigate these side effects and improve the patient’s quality of life during treatment.
The gut microbiome can influence the metabolism of cancer therapies. Certain bacteria in the gut can modify drugs, potentially affecting their efficacy and toxicity. Understanding the gut microbiome’s role in drug metabolism can help in tailoring treatments to improve outcomes and reduce adverse effects.
Cancer patients often experience changes in appetite and weight. A healthy gut microbiome aids in the digestion and absorption of nutrients, which is essential for maintaining strength and energy levels during treatment. Probiotics and prebiotics may help support gut health and improve nutritional status.
The gut-brain axis, a bidirectional communication pathway between the gut and the brain, can impact mental health. Anxiety, depression, and cognitive changes are common in cancer patients, and a healthy gut microbiome can help regulate mood and cognitive function.
Emerging research suggests that the composition of the gut microbiome can affect the response to immunotherapy, a type of cancer treatment that harnesses the body’s immune system to fight cancer. Certain gut bacteria have been associated with better responses to immunotherapy, highlighting the potential of microbiome-targeted therapies.
Research into the microbiome and its possible affect on MM is still relatively new. I have linked studies below that I believe will shed light on this general issue.
As both a MM survivor and MM cancer coach, I think the NDMM patient may want to understand:
If you are interested in learning more about anti-angiogenic supplement to complement your myeloma diet, email me at David.PeopleBeatingCancer@gmail.com
Thank you,
“Individuals on an intermittent-fasting and protein-pacing (IF-P) diet had fewer gastrointestinal symptoms and increased diversity in gut microbiota than those on a calorie-restricted (CR) Mediterranean-style diet in a small, randomized trial…
TAKEAWAY:
“The gut commensal microbes modulate human immunity and metabolism through the production of a large number of metabolites, which act as signaling molecules and substrates of metabolic reactions in a diverse range of biological processes.
There is a growing appreciation for the importance of immunometabolic mechanisms of the host-gut microbiota interactions in various malignant tumors. Emerging studies have suggested intestinal microbiota contributes to the progression of multiple myeloma.
In this review, we summarized the current understanding of the gut microbiome in MM progression and treatment, and the influence of alterations in gut microbiota on treatment response and treatment-related toxicity and complications in MM patients undergoing hematopoietic stem cell transplantation (HSCT).
Furthermore, we discussed the impact of gut microbiota-immune system interactions in tumor immunotherapy, focusing on tumor vaccine immunotherapy, which may be an effective approach to improve anti-myeloma efficacy…”